Chinese Acute Ischemic Stroke Treatment Outcome Registry
NCT ID: NCT02470624
Last Updated: 2015-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2015-05-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endovascular treatmenT for Acute Ischemic Stroke in China
NCT04752735
Early Neurological Trajectory and Clinical Outcomes in Brain Acute Ischemic Stroke
NCT06170086
REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry Occlusion
NCT05311605
Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
NCT05779215
Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients
NCT05988125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment following current guideline
treatment following current guideline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
treatment following current guideline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. confirmed diagnosis of an ischemic stroke
3. admission within 1 week after onset of stroke or within treatment time window for patients of thrombolysis treatment
4. signed informed consent
Exclusion Criteria
2. with severe morbid (estimated survival duration less than 3 months)
3. could not provide follow-up information
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Techpool Bio-Pharma Co., Ltd.
INDUSTRY
Peking University First Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yining Huang
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yining Huang, MD
Role: PRINCIPAL_INVESTIGATOR
Peking University First Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University First Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Huang D, Lu Y, Sun W, Sun W, Sun Y, Huang Y, Song Y, Tai L, Li G, Chen H, Zhang G, Zhang L, Sun X, Qiu J, Wei Y, Jin H. Functional Outcomes of Human Urinary Kallindinogenases in Treatment of Acute Ischemic Stroke. Stroke. 2025 Sep 29. doi: 10.1161/STROKEAHA.124.050188. Online ahead of print.
Lu Y, Sun W, Huang Y, Wang Z, Shen Z, Sun W, Liu R, Li F, Shu J, Peng Q, Jia J, Sun P, Song Y, Jin H; CASTOR Investigators. Comparison of Factors Affecting Quality of Life in Patients with Acute Ischemic Stroke Across Different Stroke Severities. Neurol Ther. 2025 Jun;14(3):1023-1038. doi: 10.1007/s40120-025-00743-9. Epub 2025 Apr 29.
Wang L, Guan X, Zhou J, Hu H, Liu W, Wei Q, Huang Y, Sun W, Jin X, Li H. Measuring the health outcomes of Chinese ischemic stroke patients based on the data from a longitudinal multi-center study. Qual Life Res. 2025 Jul;34(7):1967-1977. doi: 10.1007/s11136-025-03957-4. Epub 2025 Mar 27.
Lu Y, Sun P, Jin H, Wang Z, Shen Z, Sun W, Sun Y, Liu R, Li F, Shu J, Qiu Z, Lu Z, Sun W, Zhu S, Huang Y; CASTOR Investigators. Prolonged Hospital Length of Stay Does Not Improve Functional Outcome in Acute Ischemic Stroke. Neurol Ther. 2025 Apr;14(2):593-607. doi: 10.1007/s40120-025-00712-2. Epub 2025 Feb 18.
Li Y, Ou Q, Lu Y, Shen Z, Li J, Zhang Z, Tai L, Li G, Chen H, Zhang G, Zhang L, Sun X, Qiu J, Wei Y, Zhu S, Wang Z, Sun W, Huang Y. Geographic differences in pharmacotherapy patterns and outcomes of acute ischemic stroke in China. BMC Neurol. 2024 Feb 15;24(1):64. doi: 10.1186/s12883-024-03564-9.
Sun W, Ou Q, Zhang Z, Qu J, Huang Y. Chinese acute ischemic stroke treatment outcome registry (CASTOR): protocol for a prospective registry study on patterns of real-world treatment of acute ischemic stroke in China. BMC Complement Altern Med. 2017 Jul 6;17(1):357. doi: 10.1186/s12906-017-1863-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Neurology-stroke
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.